This event discussed vaccination and assisted conception. A film of the event can be watched here.
The event was chaired by Sarah Norcross, with speakers including Jason Kasraie, Dr Sigal Klipstein and Dr Anna Veiga. Find out more about the speakers and chair here.
The event was produced by the Progress Educational Trust (PET), and was sponsored by the Edwards and Steptoe Research Trust Fund, the British Fertility Society, the Bristol Fertility Clinic and CooperSurgical.
The themes of the event are set out below.
It is hoped that vaccination programmes to address the coronavirus/COVID-19 pandemic will - in due course - benefit people who are seeking, undergoing and providing fertility treatment.
The Association of Reproductive and Clinical Scientists (ARCS) and the British Fertility Society (BFS) have said: 'It is expected that access to the vaccine will allow vulnerable patient groups to be able to access fertility treatment that may have been paused during the pandemic. It will also help clinics develop resilience among their workforce by reducing the likelihood of illness and the need to self-isolate.'
Vaccination offers hope, but at the same time, it raises practical and safety considerations for fertility treatment.
UK professional bodies including ARCS and the BFS - and professional bodies elsewhere in the world, including the European Society of Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM) - have offered guidance on whether and when COVID vaccination is advisable in the context of assisted conception, and in relation to conception and pregnancy more generally.
At this PET event, experts representing different professional bodies discussed their guidance and their thinking on this area. Issues explored included the timing of vaccination in relation to fertility treatment, and - conversely - the timing of fertility treatment in relation to vaccination.